|
National Stock Number(NSN): 6505-01-004-3546 (6505010043546, 010043546)
| NIIN: |
01-004-3546 |
Item Name: |
TRIFLUOPERAZINE HYDROCHLORIDE TABLETS |
INC: |
34212
|
| FSC: |
6505
|
Assignment Date: |
May-30-1975 |
CRIT: |
X |
IIG: |
34212 |
| ISC: |
5 |
Date Standardized: |
Jun-12-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9235 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
484-0S07-21 |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
3 |
9 |
4 |
75 |
1 |
D |
|
|
|
|
|
STELAZINE |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
5 |
9 |
4 |
75 |
1 |
B |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
10.000 MILLIGRAMS TRIFLUOPERAZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
10.000 TABLETS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| FEAT |
SPECIAL FEATURES |
ADMINISTRATION:ORAL NONCHEWABLE; |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|